Ricardo Pereira Mestre

13PUBLICATIONS
125CO-AUTHORS
Toxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 27, 2026
Imaging and Clinical Correlates of [177Lu]Lu-PSMA PET-Defined Eligibility in De Novo Metastatic Prostate Cancer.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Jan 25, 2026
Risk of bone fractures in patients with prostate cancer treated with maximal androgen blockade therapy: a systematic literature review and meta-analysis.

Isabella Saporita, Mariangela Calabrese, Federica Maria Carfi

|Jan 10, 2026
ChronoimmunoTOX: A Single-Institution Retrospective Study on How the Time of Administration Impacts Immune Checkpoint Inhibitor Efficacy and Toxicity in Melanoma.

Alessandro Nepote, Gilles Burghgraeve, Martino Pedrani

|Dec 11, 2025
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations.

Giuseppe Salfi, Martino Pedrani, Amos Colombo

|Jun 13, 2025
Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting.

Martino Pedrani, Giuseppe Salfi, Sara Merler

Pageof 3

Frequent Collaborators

8 joint publications

Silke Gillessen

6 joint publications

Martino Pedrani

5 joint publications

Sara Merler

5 joint publications

Ursula Vogl